Literature DB >> 57638

Antibody activity of heavy and light chains and recombined IgG of human IgG anti-D.

O Forre, T E Michaelesen, J B Natvig.   

Abstract

Four human sera with high titers of IgG anti-D were studied in recombination experiments with isolated heavy and light chain. The binding to the D antigen measured by hemagglutination with O,R1R2 erythrocytes was 30-60 times weaker with isolated anti-D heavy chains and with hybrids of anti-D heavy chains and pooled light chains than with the parent anti-D IgG. Light chains and hybrids of light chains from anti-D IgG and pooled heavy chains showed no binding. This indicates that the heavy chains are more important in antigen binding than the light chains in this system. It was also shown that the idiotypes need both heavy and light chains of the anti-D molecule to give a positive reaction with specific anti-idiotypic antiserum.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57638     DOI: 10.1111/j.1365-3083.1976.tb03002.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Conversion of incomplete antibodies to direct agglutinins by mild reduction: evidence for segmental flexibility within the Fc fragment of immunoglobulin G.

Authors:  D G Romans; C A Tilley; M C Crookston; R E Falk; K J Dorrington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

2.  Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis.

Authors:  G K Endresen
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Idiotypes of inulin-binding myeloma proteins localized to variable region light and heavy chains: genetic significance.

Authors:  R Lieberman; M Vrana; W Humphrey; C C Chien; M Potter
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

4.  Serological detection of variable region (Vh) subgroups of Ig heavy chains.

Authors:  O Forre; J B Natvig; H G Kunkel
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.